Paxillin null embryonic stem cells are impaired in cell spreading and tyrosine phosphorylation of focal adhesion kinase.
about
Gene function in early mouse embryonic stem cell differentiation.RNF5, a RING finger protein that regulates cell motility by targeting paxillin ubiquitination and altered localizationLeupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cellsLeupaxin is similar to paxillin in focal adhesion targeting and tyrosine phosphorylation but has distinct roles in cell adhesion and spreading.NMR solution structure of the focal adhesion targeting domain of focal adhesion kinase in complex with a paxillin LD peptide: evidence for a two-site binding modelPaxillin mediates sensing of physical cues and regulates directional cell motility by controlling lamellipodia positioningMutations in the paxillin-binding site of integrin-linked kinase (ILK) destabilize the pseudokinase domain and cause embryonic lethality in micePlasma membrane profiling defines an expanded class of cell surface proteins selectively targeted for degradation by HCMV US2 in cooperation with UL141Roles of paxillin family members in adhesion and ECM degradation coupling at invadosomesInteractions between E6, FAK, and GIT1 at paxillin LD4 are necessary for transformation by bovine papillomavirus 1 E6Paxillin contracts the osteoclast cytoskeletonPaxillin enables attachment-independent tyrosine phosphorylation of focal adhesion kinase and transformation by RAS.Minimal features of paxillin that are required for the tyrosine phosphorylation of focal adhesion kinaseTransformation by bovine papillomavirus type 1 E6 requires paxillin.Human papillomavirus E6 regulates the cytoskeleton dynamics of keratinocytes through targeted degradation of p53Erk1/2 MAPK and caldesmon differentially regulate podosome dynamics in A7r5 vascular smooth muscle cells.TRIM15 is a focal adhesion protein that regulates focal adhesion disassembly.Hyaluronan keeps mesenchymal stem cells quiescent and maintains the differentiation potential over time.Paxillin regulates androgen- and epidermal growth factor-induced MAPK signaling and cell proliferation in prostate cancer cells.Activation of PKCβII by PMA facilitates enhanced epithelial wound repair through increased cell spreading and migration.Extracellular matrix, junctional integrity and matrix metalloproteinase interactions in endothelial permeability regulation.Interaction between mDia1 and ROCK in Rho-induced migration and adhesion of human dental pulp cells.Physiologic properties and regulation of the actin cytoskeleton in vascular smooth musclePaxillin: a crossroad in pathological cell migrationPaxillin controls endothelial cell migration and tumor angiogenesis by altering neuropilin 2 expression.Talin-bound NPLY motif recruits integrin-signaling adapters to regulate cell spreading and mechanosensing.Kindlin-2 cooperates with talin to activate integrins and induces cell spreading by directly binding paxillin.Deregulation of focal adhesion formation and cytoskeletal tension due to loss of A-type lamins.Myoferlin depletion elevates focal adhesion kinase and paxillin phosphorylation and enhances cell-matrix adhesion in breast cancer cells.Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer cells.Multiple paxillin binding sites regulate FAK function.Dasatinib inhibits actin fiber reorganization and promotes endothelial cell permeability through RhoA-ROCK pathwayNrk2b-mediated NAD+ production regulates cell adhesion and is required for muscle morphogenesis in vivo: Nrk2b and NAD+ in muscle morphogenesis.Tenascin-C blocks cell-cycle progression of anchorage-dependent fibroblasts on fibronectin through inhibition of syndecan-4.Endothelial paxillin and focal adhesion kinase (FAK) play a critical role in neutrophil transmigration.
P2860
Q21093367-8804AAEC-0B28-47F1-99C8-0D6D9032ABC7Q24308703-12B3B824-CD27-46E6-87BD-C56F78BFEEFDQ24308733-90708FF8-E76F-4E38-8DF1-9332B76653A1Q24319896-7A64DB5A-60F3-4405-AA97-D99CD345D179Q27642755-74B014E7-DCA5-4192-A302-8B9987F61EDBQ28478399-373480DD-1B99-4774-BE3B-CA89EE0581D2Q28508913-E775C4BD-21EC-49B3-A5D0-456048057BF2Q28546343-EA103A89-5966-4E2E-B330-9F9C46B05BCBQ30276655-17666EDA-6B08-4F31-A249-9BC2C58CC303Q30407781-980602E1-FE6E-4FA3-BA32-BBA55DC295DEQ30416067-390AE4CA-C794-460C-BAC9-0E01F0F35609Q30424126-A049C7D3-9BA5-4AC3-9DE8-2A660FD68B38Q30438510-F335F628-85C6-4AAC-879E-A63A7CC75036Q30441087-36ED62F5-EADA-4146-B080-FA9504529E55Q30443519-BE26A827-3DB2-4674-AF20-0EB47E856C04Q30480258-3A0D54E0-66B6-4CAA-8356-FF032A799ABEQ30586940-7974F387-1B34-491B-A789-E5779B007ECEQ33638958-2B2AD7C4-C26A-462F-BD41-7BE5DA05F579Q34121332-27A96CD1-90E6-4301-A923-E9E40FED9B66Q34586273-BB00EC84-6596-459B-BFF9-6A66B138190BQ34774000-A0135E6F-DB0B-42CA-BDF0-E08ED07F94D4Q35853552-91864FB8-1E3F-48B7-8D38-8761D22E97F2Q36677467-8E2E149D-8E0B-4D0E-A49A-2FCDFE3546BEQ37650990-1E544653-4F2C-4820-BBDF-C7221BEDFB98Q37702693-0349138B-1885-429E-9E78-9949B97F0CC7Q37729697-6C79F674-7A2B-4A04-882B-B09E6734E1A1Q38358692-B352D8EF-FBD9-4844-900E-DBB0E5D0B44DQ38441084-BB24EF7C-B436-435D-A172-9B7C06277AB4Q38915438-DCE43D90-C88B-4644-BF8B-73F179A201ADQ40165268-67511A28-F6E5-4AE2-AAAD-B019159A5184Q41856148-0186D3DB-2A53-4509-BCA6-8B28BF5570C9Q42292312-E2865652-3427-4101-B0DD-A27F1E07F562Q42568079-97DD4412-0E44-4914-97D4-3BA5C0ECC504Q42800490-FAF77A60-7D9F-478F-BA82-8FCCEEEA67B0Q52618440-FC3F5F9C-38C4-4C10-A102-4567E9CD49AA
P2860
Paxillin null embryonic stem cells are impaired in cell spreading and tyrosine phosphorylation of focal adhesion kinase.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Paxillin null embryonic stem c ...... tion of focal adhesion kinase.
@en
type
label
Paxillin null embryonic stem c ...... tion of focal adhesion kinase.
@en
prefLabel
Paxillin null embryonic stem c ...... tion of focal adhesion kinase.
@en
P2093
P2860
P356
P1433
P1476
Paxillin null embryonic stem c ...... tion of focal adhesion kinase.
@en
P2093
Joanna Bohl
Ramon Wade
Scott Vande Pol
P2860
P2888
P304
P356
10.1038/SJ.ONC.1205013
P407
P577
2002-01-01T00:00:00Z
P5875
P6179
1031233256